Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1390478 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $10.10Day +0.10%Mkt cap $1.9B1Y +497.6%Off 52W high −36.4%Vol (1Y) 102.6%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,148 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest29.7% of sh out |
| Days to cover5.9d |
| 13F net flow (QoQ)+7.95% |
| Top-10 13F concentration76.0% |
| Next report (est.)2026-08-11 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$0 |
| Earnings (TTM)-$29.5M |
| ROE−66.9% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+167.9% |
| 1Y+497.6% |
| 3Y+515.9% |
| 5Y+16.2% |
| Since incept. (ann.)−34.8% |
Total return through 2026-07-29 · series begins 2017-12-29. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)102.6% |
| Ann. volatility (3Y)95.3% |
| Sharpe (1Y)2.23 |
| Sharpe (3Y)1.12 |
| Max drawdown (1Y)−36.2% |
| Max drawdown (3Y)−72.0% |
| Beta (3Y vs SPY)1.64 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 12.2M | $52M | 6.56% | +61.8% |
| STATE STREET CORP | 8.4M | $36M | 4.51% | +283.7% |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.5M | $32M | 4.05% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 3.9M | $17M | 2.10% | +27.1% |
| MARSHALL WACE, LLP | 2.0M | $9M | 1.10% | +52.0% |
| JONES FINANCIAL COMPANIES LLLP | 1.7M | $7M | 0.90% | +290.2% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.5M | $6M | 0.79% | new |
| MORGAN STANLEY | 1.3M | $6M | 0.72% | +50.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-12 | −$0.05 | — | — | — |
| 2025-09-30 | 2025-11-12 | −$0.06 | — | — | — |
| 2025-06-30 | 2025-08-12 | −$0.07 | — | — | — |
| 2025-03-31 | 2025-05-13 | −$0.07 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-11 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
